Gianniki Maria, Nikaina Irini, Avgerinou Georgia, Kanaka-Gantenbein Christina, Siahanidou Tania
First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, GRC.
Cureus. 2022 Mar 12;14(3):e23101. doi: 10.7759/cureus.23101. eCollection 2022 Mar.
Although galactosemia can be detected through neonatal screening, some cases are characterized by rapid and severe presentation before screening results become available. We report the case of a neonate with classic galactosemia presenting with acute liver failure and cytopenias (thrombocytopenia, anemia, and neutropenia). Neonatal screening results showed increased galactose and phenylalanine levels. The diagnosis of galactosemia was confirmed by the measurement of galactose-1-phosphate uridyltransferase (GALT) activity in erythrocytes. Two mutations of the gene (c.563 A>G [p. Q188R] and c.957C>A [p.H319Q]) were revealed. High clinical suspicion of galactosemia is crucial to identify, as early as possible, cases with classical or even unusual presentation, and to initiate early treatment that could change the disease course and improve outcomes. Cytopenias should be included in the broad phenotypic spectrum of galactosemia.
虽然半乳糖血症可通过新生儿筛查检测出来,但有些病例的特点是在筛查结果出来之前就迅速出现严重症状。我们报告了一例患有经典型半乳糖血症的新生儿,其表现为急性肝衰竭和血细胞减少(血小板减少、贫血和中性粒细胞减少)。新生儿筛查结果显示半乳糖和苯丙氨酸水平升高。通过测定红细胞中半乳糖-1-磷酸尿苷转移酶(GALT)活性,确诊为半乳糖血症。发现该基因的两个突变(c.563 A>G [p.Q188R] 和 c.957C>A [p.H319Q])。高度怀疑半乳糖血症对于尽早识别典型甚至非典型表现的病例并启动可能改变疾病进程和改善预后的早期治疗至关重要。血细胞减少应纳入半乳糖血症广泛的表型谱中。